Long-term use of PPIs linked to stomach cancer
The long-term use of proton pump inhibitors, a class of drugs commonly used to treat acid reflux, is linked to the risk of developing stomach cancer...
List view / Grid view
News
Wickham Laboratories announces expansion of media preparation facilities
Wickham Laboratories expands capacity for in-house media preparation...
Systematic review looks at the effectiveness and side effects of mefloquine
Researchers have published two systematic reviews revealing the safety of mefloquine for preventing malaria in travellers...
Exhibitors count down the days to Lab Innovations 2017
It’s less than a week before Lab Innovations 2017 begins, and preparations are in full swing as the NEC Birmingham gets ready to open its doors and welcome over 130 exhibitors showcasing the latest analytical, biotech and laboratory products...
Almac Group announces successful MHRA inspection at Charnwood facilities
Almac Group, the Craigavon based global contract pharmaceutical development and manufacturing organisation, is pleased to announce the successful inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its new Pharmaceutical Development & Manufacturing facilities at Charnwood Campus, Loughborough...
Focused ultrasound shows promise for treating Parkinson’s tremor
Study examines potential of scalpel-free surgery to manage tremor...
Smart artificial beta cells could lead to new diabetes treatment
Researchers have designed synthetic beta cells that secrete insulin in response to high blood sugar...
FDA approves new dosing for Xarelto to reduce the risk of VTE
The FDA has approved the 10 mg once-daily dose of Xarelto, for reducing the continued risk of recurrent venous thromboembolism...
New treatments help those with mild, moderate and severe eczema
Crisaborole and dupilumab approved for atopic dermatitis…
New initiative to accelerate development of universal influenza vaccines
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines...
Sandoz proposed biosimilar pegfilgrastim accepted by EMA
Sandoz has announced that its biosimilar pegfilgrastim has been accepted by the EMA for regulatory review...
Researchers identify ineffectiveness of Alzheimer’s drug semagacestat
Scientists have found that some potential γ-secretase inhibitors such as semagacestat, do not function as true inhibitors as originally expected...
FDA collaboration uses Organs-on-Chips to improve drug development
FDA collaboration will characterise the performance of Organs-on-Chips as a platform for potential use in drug development and regulatory evaluation...
Tarloxitinib puts tumour-seeking tail on anti-EGFR drug to target lung cancer
Researchers have proposed a unique way to reach the concentration of anti-EGFR drug needed to fight exon 20 insertions without harming healthy tissues...
17th Annual Strategic Project & Portfolio Management for Pharma
With ongoing and ever tightened budget cuts, pharma companies are struggling to prioritise projects with limited R&D budget – whilst at the same time the patent cliff is drying up the product pipeline which will have immense aftermaths of the company’s revenue stream...
